Minimal HER1 and HER2 expressions in CHO and HEK-293 cells cause them appropriate negative cells for HERs-related studies

Background: Understanding of cellular and molecular mechanisms involved in cell/tumor growth and progression has led to molecular-targeted therapy. HER1 and HER2 are two main oncogenic components of HER-receptor family considered as targets for cancer research and therapy. Reliable results of HER- r...

Full description

Bibliographic Details
Main Authors: Abasalt Hosseinzadeh Colagar, Omolbanin Amjadi, Reza Valadan, Alireza Rafiei
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences and Health Services 2013-11-01
Series:Research in Molecular Medicine
Subjects:
Online Access:http://rmm.mazums.ac.ir/browse.php?a_code=A-10-26-19&slc_lang=en&sid=1